Point72 Asia (Singapore) Pte. Ltd. Cv Rx, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 876 shares of CVRX stock, worth $10,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
876Holding current value
$10,608% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$49.7 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$28.7 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$9.98 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$8.27 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $249M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...